Amneal accelerates production of hydroxychloroquine sulfate

Amneal accelerates distribution and production of hydroxychloroquine sulfate to meet potential needs of covid-19 patients nationwide.amneal pharmaceuticals - ramping up production of hydroxychloroquine sulfate & expects to produce about 20 million tablets between now & mid-april.amneal pharma - co's hydroxychloroquine sulfate tablets approved by fda to treat malaria, rheumatoid arthritis, lupus, childhood arthritis, others.
AMRX Ratings Summary
AMRX Quant Ranking